Soliris 300 mg/30 mL (10 mg/mL) injection Images
Generic Name: eculizumab
This medication has been identified as Soliris 300 mg/30 mL (10 mg/mL) injection and is used for Neuromyelitis Optica Spectrum Disorder, Hemolytic Uremic Syndrome, Myasthenia Gravis, and Paroxysmal Nocturnal Hemoglobinuria. It belongs to the drug class selective immunosuppressants and is not a controlled substance.
Images of medication
Soliris
- Generic Name
- eculizumab
- Strength
- 300 mg/30 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alexion Pharmaceuticals Inc.
- National Drug Code (NDC)
- 25682-0001
See also:
More about Soliris (eculizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.